Finding Solutions to the Latest Challenges in Rx Drug Pricing

With both federal and state law makers engaging in greater scrutiny of prescription drug pricing, now is the time when industry professionals must stay up to date on the latest amendments to government payor programs as well as their impact on the private sector.

ACI’s Rx Drug Pricing Forum will provide you with the guidance you need to formulate solutions to conquer the latest challenges drug manufacturers are facing in the public payor arena.

 


HHS Keynote Address: An Inside
Perspective on Pricing Reform Initiatives



John O’Brien
Senior Advisor to the Secretary
for Drug Pricing Reform
U.S. Department of Health
and Human Services

Industry Keynote Address: Industry
Perspectives on the Public Payor Landscape



James Stansel
Executive Vice President
and General Counsel
PhRMA

 

Enforcers Roundtable on Rx Drug Pricing
 

Viveca Parker
Assistant U.S. Attorney
The United States Attorney’s Office for the Eastern District of Pennsylvania
Steve Sharobem
Assistant U.S. Attorney
The United States Attorney’s Office for the District of Massachusetts

 

NEW for 2019:

  • The latest amendments to Medicare parts B and D under the CMS Proposed Final Rule
  • The future of the PHS’s 340B program in the aftermath of American Hospital Association v. Azar
  • The perplexities of co-pay coupons, maximizers and accelerators
  • The expansion of federal and state transparency measures in relation to pricing
  • The role of online pharmacies in the drug pricing debate
  • The impact of pharmaceutical industry verticalization on prescription drug pricing under the Medicare and Medicaid programs

Don’t miss out on the pre-conference workshops to receive a full understanding of necessary pharmaceutical pricing concepts:

Workshop A
Government Payor Programs 101:
Primer on the Pricing Essentials of the Medicare, Medicaid, and Big Four Programs

 

LEARN MORE

Workshop B
Medicare and Medicaid Pricing 2.0: Developing Practical Strategies for
Complex Pricing Challenges

 

LEARN MORE

 

Don’t miss this opportunity to benchmark your drug pricing strategies with top industry representatives. Register early to secure your place!


What Past Attendees Say:

“Excellent and fully capable list of speakers”
-VP US Commercial Legal, Lundbeck LLC

“All encompassing overview of government programs and current issues”
-Director, Pricing and Contracts, Horizon Pharmaceuticals


Who You Will Meet:

Pharmaceutical Companies

  • Corporate Counsel/General Counsel
  • Vice Presidents, Officers, Directors and Managers for:
    • — Pricing, Pricing Strategy,
      Pricing Analytics
    • — Contracts and
      Reimbursement
    • — Managed Care
    • — Government Programs
    • — Medicaid/Medicare
      Rebates
    • — Finance/Accounting/Audit
    • — Government Affairs
    • — Marketing
  • Compliance Officers


Law Firms

  • Attorneys with practice areas in:
    • — Pharmaceuticals
    • — Healthcare
    • — Food & Drug

PBMs

  • Corporate Counsel/General Counsel
  • Vice Presidents, Officers, Directors and Managers for:
    • — Contract Management
    • — Network Pharmacy
    • — Retail Pharmacy Operations
    • — Government Programs
    • — Pricing and Operations
    • — Clinical Operations
    • — Industry Relations/Government Affairs
  • Financial Analysts


Pharmacies

  • Corporate Counsel/General Counsel
  • Vice Presidents, Officers, Directors and Managers for:
  • Pricing
  • Business Development


Plans

  • Corporate Counsel/General Counsel
  • Vice Presidents, Officers, Directors and Managers for:
    • — Pharmacy Networks
    • — Pharmaceutical Contracting
    • — Clinical
    • — Pharmacy Services

2019 AGENDA
IS AVAILABLE

--------------

CLICK HERE TO DOWNLOAD

 
Think Tank on Health Outcomes, Market Access and Value Based Contracting
 

Enhance your learning and networking experiences by attending the 1-Day Health Outcomes Think Tank

An open symposium where you can explore, debate, and discuss the challenges associated with developing successful strategies to present and evaluate proofs which both public and private payors are requiring to achieve positive formulary determinations.

LEARN MORE

 

Event Contacts

For media partnership opportunities please contact:

Andrea Sachs
Tel: 212-352-3220 ext. 5224
[email protected]


For sponsorship opportunities please contact:

[email protected]


For speaking opportunities please contact:

Marc Gerstein
Tel: 212.352.3220 ext. 5530
[email protected]